LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 3,470 | 1,593 | 809 | 0 | 0 |
| Cost of Goods | 256 | 129 | 58 | N/A | 0 |
| Gross Profit | 3,214 | 1,464 | 751 | N/A | N/A |
| Operating Expenses | 51,834 | 53,160 | 51,503 | 38,846 | 26,483 |
| Operating Income | -48,364 | -51,567 | -50,694 | -38,846 | -26,483 |
| Interest Expense | 2,926 | 1,654 | 0 | 0 | -195 |
| Other Income | 545 | 443 | 166 | 300 | 0 |
| Pre-tax Income | -50,745 | -52,778 | -50,528 | -38,546 | -26,288 |
| Net Income Continuous | -50,745 | -52,778 | -50,528 | -38,546 | -26,288 |
| Net Income | $-50,745 | $-52,778 | $-50,528 | $-38,546 | $-26,288 |
| EPS Basic Total Ops | -1.93 | -2.02 | -2.22 | -1.75 | -1.19 |
| EPS Basic Continuous Ops | -1.93 | -2.02 | -2.22 | -1.75 | -1.19 |
| EPS Diluted Total Ops | -1.93 | -2.02 | -2.22 | -1.75 | -1.19 |
| EPS Diluted Continuous Ops | -1.93 | -2.02 | -2.22 | -1.75 | -1.19 |
| EBITDA(a) | $-47,207 | $-50,471 | $-49,702 | $-38,477 | $-26,165 |